NCT02664389View on ClinicalTrials.gov

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

NACompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Breast CancerOvarian CancerColorectal CancerPediatric CancersMultiple Primary Malignant Tumours
Interventions
GENETIC

Genetic analysis

Sequencing of 200 selected genes in the different study populations

Trial Locations (1)

76031

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT02664389 - Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation | Biotech Hunter | Biotech Hunter